Sort by
Updated Top 20 Option Holders Report
Change of Director's Interest Notice
Top 20 Optionholders and Distribution List
Application for quotation of securities - PER
Notification regarding unquoted securities - PER
Update - Proposed issue of securities - PER
Update - Proposed issue of securities - PER
Update - Proposed issue of securities - PER
Prospectus - Placement options and JLM options
FDA Clearance for Vanderbilt Health Clinical Trial in AML
| Date | Headline |
|---|---|
6 Nov 2026 | Updated Top 20 Option Holders Report |
6 Nov 2026 | Change of Director's Interest Notice |
6 Nov 2026 | Top 20 Optionholders and Distribution List |
6 Nov 2026 | Application for quotation of securities - PER |
6 Nov 2026 | Notification regarding unquoted securities - PER |
4 Nov 2026 | Update - Proposed issue of securities - PER |
4 Nov 2026 | Update - Proposed issue of securities - PER |
4 Nov 2026 | Update - Proposed issue of securities - PER |
4 Nov 2026 | Prospectus - Placement options and JLM options |
2 Nov 2026 | FDA Clearance for Vanderbilt Health Clinical Trial in AML |
Investor presentations
Updates
Sort by